PeptidePrices safety rating
7/10 · Not FDA-approved
HGH Fragment 176-191 Prices
14 vendors · 4 with an issuer-verified COA · lowest 10mg from $45.00 · checked
Where to buy HGH Fragment 176-191: 14 vendors compared
| Vendor | Price | Actions |
|---|---|---|
| $45.00 | Buy HGH Fragment 176-191 from Elite Edge Biotech | |
| $63.74 | Buy HGH Fragment 176-191 from Swift Peptides | |
| $65.0010mg packageChecked today | Buy HGH Fragment 176-191 from Elite RX Labs | |
| 3-test panelVerified COAFreedom Diagnostics · Tested Mar 3, 2026 | $71.98 | Buy HGH Fragment 176-191 from Alera Research |
| $71.98 | Buy HGH Fragment 176-191 from T-Core Biotech | |
| COA on fileMarfleet Analytical Services · Tested Jun 19, 2026 | $76.162 × 5mg packages · 10mg totalChecked today | Buy HGH Fragment 176-191 from Pure Peptides UK |
| 4-test panelVerified COAFreedom Diagnostics · Tested Feb 16, 2026 | $84.98 | Buy HGH Fragment 176-191 from SomaChems |
| $86.38 | Buy HGH Fragment 176-191 from Vital Core Research | |
| 4-test panelVerified COALiquilabs · Tested Sep 8, 2026 | $86.7710mg packageChecked Oct 7 | Buy HGH Fragment 176-191 from Adria Science |
| $88.002 × 5mg packages · 10mg totalChecked today | Buy HGH Fragment 176-191 from Pure Peptides | |
| $110.38 | Buy HGH Fragment 176-191 from Cenexa Labs | |
| $115.202 × 5mg packages · 10mg totalChecked today | Buy HGH Fragment 176-191 from StrikePoint Peptides | |
| 2-test panelVerified COAOptima Labs | $117.982 × 5mg packages · 10mg totalChecked Oct 4 | Buy HGH Fragment 176-191 from Peptides Lab UK |
| $150.002 × 5mg packages · 10mg totalChecked today | Buy HGH Fragment 176-191 from Alpha Carbon Labs |
Tracked every day
HGH Fragment 176-191 listing prices, tracked daily
The five cheapest in-stock package prices for HGH Fragment 176-191 on each collected day, and the vendors that most often held those places.
Five cheapest in-stock package prices per day
Listed package price before coupons, any vial size. This is not the coupon-adjusted lowest 10mg price used to rank the comparison.
- Cheapest$19.24
- 2nd cheapest$38.08
- 3rd cheapest$39.99
- 4th cheapest$44.00
- 5th cheapest$44.99
Vendors most often in the cheapest five
- Pure Peptides UK36 days$38.08+97.9%
- T-Core Biotech22 days$44.990.0%
- Alera Research17 days$39.990.0%
- Vital Core Research11 days$53.99last seen Oct 7, 20260.0%
- Elite Edge Biotech8 days$25.00last seen Oct 2, 20260.0%
- Elite RX Labs4 days$65.00last seen Sep 23, 20260.0%
- Pure Peptides3 days$44.000.0%
- Alpha Carbon Labs2 days$75.00last seen Sep 22, 20260.0%
Top 8 of 10 vendors that reached the cheapest five
Current market data
HGH Fragment 176-191 Price Report
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for HGH Fragment 176-191 is $45.00 from Elite Edge Biotech. The median across vendors is $85.68.
- Lowest 10mg cost
- $45.00Elite Edge Biotech
- Median 10mg cost
- $85.68One normalized offer per vendor
- Lowest package total
- $19.24Pure Peptides UK · package size may differ
- Public COA coverage
- 100%14 of 14 vendors
What the market shows
PeptidePrices found 16 in-stock listings from 14 vendors, checked through Oct 10, 2026. The lowest 10mg cost is 47% below the vendor median of $85.68; 7 vendors (50%) fall below that median. 14 of 14 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
How this report is calculated
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
What is HGH Fragment 176-191? Research, safety, and status
HGH Fragment 176-191 at a glance
Mechanism
C-terminal fragment of HGH (amino acids 176-191); selectively activates fat cell beta-3 adrenergic receptors to stimulate lipolysis; inhibits lipogenesis without affecting IGF-1 or causing hyperglycemia.
Research areas
Fat loss / targeted lipolysis; obesity; metabolic enhancement. Does not increase muscle growth or cause HGH side effects.
Regulatory / research status
Research / preclinical only
Half-life
~30 minutes.
Storage
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Reported side effects
Minimal. No glucose dysregulation. No cancer risk from IGF-1 elevation.
Similar to AOD-9604; designed to avoid full GH side effects; no IGF-1 elevation; well-tolerated anecdotally Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Study highlights
- HGH Fragment 176-191 (AOD9604), a 16-amino-acid C-terminal fragment of hGH with a Tyr→Phe substitution at position 177, produces fat-selective lipolytic effects without binding the hGH receptor, without stimulating IGF-1 production, and without affecting insulin sensitivity or promoting tissue growth, demonstrating that the growth and metabolic functions of hGH are structurally separable.
- Chronic treatment with AOD9604 in obese mice reduced body weight, increased in vivo fat oxidation, and elevated plasma glycerol (index of lipolysis); crucially, beta-3 adrenergic receptor knockout mice were unresponsive to AOD9604, identifying beta-3 AR upregulation as an obligate downstream mechanism for long-term lipolytic effects.
- In obese mice, oral AOD9604 administered for 30 days significantly reduced body weight gain, increased in vitro lipolytic activity, and decreased lipogenic activity in isolated human adipose tissue, providing the preclinical basis for human trials.
- A 12-week randomized human trial demonstrated approximately 1.8 kg greater weight loss vs. placebo; however, larger trials failed to achieve primary endpoints and Metabolic Pharmaceuticals discontinued development in 2007, highlighting that robust preclinical lipolytic effects in rodents have not translated to clinically meaningful fat loss in humans.
Selected references
- The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice and Beta(3)-AR Knock-Out Mice · Endocrinology, 2001
- Increase of Fat Oxidation and Weight Loss in Obese Mice Caused by Chronic Treatment with Human Growth Hormone or a Modified C-Terminal Fragment · Int J Obes, 2001
- Effects of Oral Administration of a Synthetic Fragment of Human Growth Hormone on Lipid Metabolism · Am J Physiol Endocrinol Metab, 2000
- Safety and Tolerability of AOD-9604 in Humans · J Endocrinol Metab, 2013
Related pages